title: [Down syndrome maternal serum screening: results' comments recommended by accredited biologists].
abstract: Down syndrome maternal serum screening is largely used in France. The aim of this article is to specify and to explain the different comments applied on the reports in order to optimize the management of the patient. These comments represent the consensus of the study group of the biologist accredited for Down syndrome maternal serum screening.
authors.affiliation: Service de biochimie-hormonologie, hôpital Robert-Debré, 48, boulevard Sérurie, 75019 Paris, France. Electronic address: francoise.muller@rdb.aphp.fr.
authors.forename: F
authors.initials: F
authors.lastname: Muller
authors.affiliation: Service de biochimie-hormonologie, hôpital Robert-Debré, 48, boulevard Sérurie, 75019 Paris, France.
authors.forename: S
authors.initials: S
authors.lastname: Dreux
authors.affiliation: Service de biochimie-hormonologie, hôpital Robert-Debré, 48, boulevard Sérurie, 75019 Paris, France.
authors.forename: I
authors.initials: I
authors.lastname: Czerkiewicz
authors.affiliation: Service de biochimie, CHU Pitié-Salpêtrière, 75013 Paris, France.
authors.forename: M
authors.initials: M
authors.lastname: Bernard
authors.affiliation: Bureau ABA, hôpital Robert-Debré, 75019 Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Guibourdenche
authors.affiliation: Bureau ABA, hôpital Robert-Debré, 75019 Paris, France.
authors.forename: I
authors.initials: I
authors.lastname: Lacroix
authors.affiliation: Bureau ABA, hôpital Robert-Debré, 75019 Paris, France.
authors.forename: M-P
authors.initials: MP
authors.lastname: Moineau
authors.affiliation: Bureau ABA, hôpital Robert-Debré, 75019 Paris, France.
authors.forename: M-H
authors.initials: MH
authors.lastname: Read
authors.affiliation: Bureau ABA, hôpital Robert-Debré, 75019 Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Sault
authors.affiliation: Bureau ABA, hôpital Robert-Debré, 75019 Paris, France.
authors.forename: D
authors.initials: D
authors.lastname: Thibaud
authors.affiliation: Bureau ABA, hôpital Robert-Debré, 75019 Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Veyrat
authors.affiliation: Centre pluridisciplinaire de diagnostic prénatal Léonard-de-Vinci (Pontoise-Argenteuil-Colombes), 95300 Pontoise, France.
authors.forename: L
authors.initials: L
authors.lastname: Bidat
mesh_terms: D015415:Biomarkers / Q000097:blood; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D032921:Consensus; D004314:Down Syndrome / Q000097:blood*; D005260:Female; D005602:France; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011266:Pregnancy-Associated Plasma Protein-A / Q000032:analysis; D011296:Prenatal Diagnosis / Q000379:methods*; D012306:Risk; D000509:alpha-Fetoproteins / Q000032:analysis
chemical_list: D015415:Biomarkers; D018997:Chorionic Gonadotropin, beta Subunit, Human; D000509:alpha-Fetoproteins; D011266:Pregnancy-Associated Plasma Protein-A; C579283:PAPPA protein, human
keywords: AFP; Dépistage sérique; Maternal serum screening; PAPP-A; Pregnancy management; Suivi de grossesse; Trisomie 21; Trisomy 21; hCG; hCGβ